中国肿瘤标志物应用现状与发展
Author:
Open Access
- 20 March 2026
- journal article
- review article
- Vol. 57 (2) , 307-312
Abstract
肿瘤标志物在早期筛查、辅助诊断、疗效评估和预后判断中的作用日益凸显,已成为肿瘤精准诊疗体系的重要组成部分。本文系统回顾了肿瘤标志物近两个世纪的发展历程,从早期蛋白类标志物演进至基因组学时代;重点阐述了我国肿瘤标志物规范化应用的基本原则、实验室应用现状,以及在肺癌、肝癌等重点癌种中的临床应用建议;并深入剖析了以液体活检技术为支撑的ctDNA基因标志物、DNA甲基化、外泌体及循环肿瘤细胞等多维度标志物研究,以及人工智能模型构建等前沿领域的研究进展及临床转化挑战,以期为我国肿瘤标志物的创新发展与规范应用提供参考,助力提升肿瘤精准防控水平。Keywords
This publication has 24 references indexed in Scilit:
- Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort studyThe Lancet Digital Health, 2024
- DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal CancerCancer Research, 2023
- A multiplex blood-based assay targeting DNA methylation in PBMCs enables early detection of breast cancerNature Communications, 2023
- Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studiesAnnals of Oncology, 2023
- Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersCell, 2020
- Emerging biomarkers in Multiple Myeloma: A reviewClinica Chimica Acta, 2020
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic DatabaseJAMA, 2019
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Tumor Markers in Cancer Diagnosis and PrognosisCA: A Cancer Journal for Clinicians, 1988
- Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras geneNature, 1982